IGC
Price
$0.30
Change
-$0.01 (-3.23%)
Updated
Jul 3 closing price
Capitalization
25.38M
35 days until earnings call
PPTDF
Price
$13.18
Change
+$2.08 (+18.74%)
Updated
Jun 25 closing price
Capitalization
1.42B
Interact to see
Advertisement

IGC vs PPTDF

Header iconIGC vs PPTDF Comparison
Open Charts IGC vs PPTDFBanner chart's image
IGC Pharma
Price$0.30
Change-$0.01 (-3.23%)
Volume$240.57K
Capitalization25.38M
Peptidream
Price$13.18
Change+$2.08 (+18.74%)
Volume$185
Capitalization1.42B
IGC vs PPTDF Comparison Chart in %
Loading...
IGC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PPTDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IGC vs. PPTDF commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IGC is a Buy and PPTDF is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 04, 2025
Stock price -- (IGC: $0.30 vs. PPTDF: $13.18)
Brand notoriety: IGC and PPTDF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IGC: 111% vs. PPTDF: 15%
Market capitalization -- IGC: $25.38M vs. PPTDF: $1.42B
IGC [@Biotechnology] is valued at $25.38M. PPTDF’s [@Biotechnology] market capitalization is $1.42B. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IGC’s FA Score shows that 0 FA rating(s) are green whilePPTDF’s FA Score has 1 green FA rating(s).

  • IGC’s FA Score: 0 green, 5 red.
  • PPTDF’s FA Score: 1 green, 4 red.
According to our system of comparison, IGC is a better buy in the long-term than PPTDF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IGC’s TA Score shows that 4 TA indicator(s) are bullish while PPTDF’s TA Score has 5 bullish TA indicator(s).

  • IGC’s TA Score: 4 bullish, 4 bearish.
  • PPTDF’s TA Score: 5 bullish, 1 bearish.
According to our system of comparison, PPTDF is a better buy in the short-term than IGC.

Price Growth

IGC (@Biotechnology) experienced а -2.42% price change this week, while PPTDF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

IGC is expected to report earnings on Aug 08, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PPTDF($1.42B) has a higher market cap than IGC($25.4M). IGC YTD gains are higher at: -9.970 vs. PPTDF (-26.162). PPTDF has higher annual earnings (EBITDA): 34.8B vs. IGC (-7.58M). PPTDF has more cash in the bank: 25.5B vs. IGC (470K). IGC has less debt than PPTDF: IGC (270K) vs PPTDF (20.9B). PPTDF has higher revenues than IGC: PPTDF (55.4B) vs IGC (1.24M).
IGCPPTDFIGC / PPTDF
Capitalization25.4M1.42B2%
EBITDA-7.58M34.8B-0%
Gain YTD-9.970-26.16238%
P/E RatioN/A16.55-
Revenue1.24M55.4B0%
Total Cash470K25.5B0%
Total Debt270K20.9B0%
FUNDAMENTALS RATINGS
IGC vs PPTDF: Fundamental Ratings
IGC
PPTDF
OUTLOOK RATING
1..100
6388
VALUATION
overvalued / fair valued / undervalued
1..100
47
Fair valued
89
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9820
PRICE GROWTH RATING
1..100
6083
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
95n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IGC's Valuation (47) in the Biotechnology industry is somewhat better than the same rating for PPTDF (89) in the null industry. This means that IGC’s stock grew somewhat faster than PPTDF’s over the last 12 months.

IGC's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as PPTDF (100) in the null industry. This means that IGC’s stock grew similarly to PPTDF’s over the last 12 months.

PPTDF's SMR Rating (20) in the null industry is significantly better than the same rating for IGC (98) in the Biotechnology industry. This means that PPTDF’s stock grew significantly faster than IGC’s over the last 12 months.

IGC's Price Growth Rating (60) in the Biotechnology industry is in the same range as PPTDF (83) in the null industry. This means that IGC’s stock grew similarly to PPTDF’s over the last 12 months.

IGC's P/E Growth Rating (100) in the Biotechnology industry is in the same range as PPTDF (100) in the null industry. This means that IGC’s stock grew similarly to PPTDF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IGCPPTDF
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
20%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
23%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
26%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
35%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
29%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
40%
Advances
ODDS (%)
Bullish Trend 12 days ago
84%
N/A
Declines
ODDS (%)
Bearish Trend 4 days ago
82%
N/A
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 4 days ago
41%
View a ticker or compare two or three
Interact to see
Advertisement
IGC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PPTDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
UTSI2.630.08
+3.14%
UTStarcom Holdings Corp
SLS2.170.05
+2.36%
SELLAS Life Sciences Group
RPT2.730.02
+0.74%
Rithm Property Trust Inc
SIG84.060.10
+0.12%
Signet Jewelers Limited
STZ172.32-1.55
-0.89%
Constellation Brands

PPTDF and

Correlation & Price change

A.I.dvisor tells us that PPTDF and HOTH have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PPTDF and HOTH's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PPTDF
1D Price
Change %
PPTDF100%
N/A
HOTH - PPTDF
31%
Poorly correlated
+0.83%
CYCC - PPTDF
28%
Poorly correlated
-4.80%
IGC - PPTDF
22%
Poorly correlated
-1.47%
LABFF - PPTDF
22%
Poorly correlated
N/A
CPMV - PPTDF
21%
Poorly correlated
+9.02%
More